| Rare Disease Lead |
Serbia |
Serbien |
International |
Innovative Medicines |
Market Access |
Okt 09, 2024 |
| Director Account Management and Pricing Strategy - Remote |
Remote Position (USA) |
USA |
US |
Innovative Medicines |
Market Access |
Okt 08, 2024 |
| RWE Lead |
Sintra |
Portugal |
International |
Innovative Medicines |
Market Access |
Okt 08, 2024 |
| Senior Team Leader Float |
INSURGENTES |
Mexiko |
US |
Innovative Medicines |
Market Access |
Okt 08, 2024 |
| Manager Economic Modelling |
Hyderabad (Office) |
Indien |
Operations |
CTS |
Market Access |
Okt 06, 2024 |
| Manager, Evidence Generation |
Hyderabad (Office) |
Indien |
Operations |
CTS |
Market Access |
Okt 03, 2024 |
| Consultant, Evidence Generation |
Hyderabad (Office) |
Indien |
Operations |
CTS |
Market Access |
Okt 03, 2024 |
| Sr. Manager Economic Modelling |
Hyderabad (Office) |
Indien |
Operations |
CTS |
Market Access |
Okt 03, 2024 |
| Senior Market Access Manager |
New South Wales (NSW) |
Australien |
International |
Innovative Medicines |
Market Access |
Sep 30, 2024 |
| P&R Manager |
Seoul |
Südkorea |
International |
Innovative Medicines |
Market Access |
Sep 27, 2024 |
| Health Technology Appraisal & HEOR Director |
London (The Westworks) |
Vereinigtes Königreich |
International |
Innovative Medicines |
Market Access |
Sep 24, 2024 |
| Head of MA South |
Guangzhou (Guangdong Province) |
China |
International |
Innovative Medicines |
Market Access |
Sep 22, 2024 |
| Associate Director RWE Manager |
Dublin (Novartis Corporate Center (NOCC)) |
Irland |
Operations |
CTS |
Market Access |
Sep 18, 2024 |
| Associate Director, Access & Reimbursement RLT - San Diego, CA - Remote |
Field Non-Sales (USA) |
USA |
US |
Innovative Medicines |
Market Access |
Sep 17, 2024 |
| Director, Channel & Pricing Strategy - Remote |
Remote Position (USA) |
USA |
US |
Innovative Medicines |
Market Access |
Sep 16, 2024 |
| Strategic Account Manager - Wales |
Field Force (England / Wales) |
Vereinigtes Königreich |
International |
Innovative Medicines |
Market Access |
Sep 10, 2024 |
| Manager, Healthcare Solutions (Private) |
Makati City |
Philippinen |
International |
Innovative Medicines |
Market Access |
Sep 06, 2024 |
| Manager, Healthcare Solutions (UHC) |
Makati City |
Philippinen |
International |
Innovative Medicines |
Market Access |
Sep 06, 2024 |
| AD, Access & Reimbursement Oncology - OH-W.VA-Western Pennsylvania - Remote |
Field Non-Sales (USA) |
USA |
US |
Innovative Medicines |
Market Access |
Sep 06, 2024 |
| AD, Access & Reimbursement NPS RLT Remote- Houston, TX |
Field Non-Sales (USA) |
USA |
US |
Innovative Medicines |
Market Access |
Sep 05, 2024 |
| Senior Public Affairs Manager (m/f/d) |
Berlin West (Non-Sales Force) (Novartis Pharma GmbH) |
Deutschland |
International |
Innovative Medicines |
Market Access |
Sep 03, 2024 |
| Innovative Access Partnerships and Engagement Manager |
İstanbul Kavacık |
Türkei |
International |
Innovative Medicines |
Market Access |
Sep 03, 2024 |
| AD, Access & Reimbursement - Minneapolis - Remote |
Field Non-Sales (USA) |
USA |
US |
Innovative Medicines |
Market Access |
Sep 03, 2024 |
| Market Access Specialist |
Hefei (Anhui Province) |
China |
International |
Innovative Medicines |
Market Access |
Sep 03, 2024 |
| Solution & Service Design Manager |
London (The Westworks) |
Vereinigtes Königreich |
International |
Innovative Medicines |
Market Access |
Aug 15, 2024 |
| Real World Evidence Research Analyst |
Dublin (Novartis Corporate Center (NOCC)) |
Irland |
Operations |
CTS |
Market Access |
Aug 12, 2024 |
| Pricing Manager |
New South Wales (NSW) |
Australien |
International |
Innovative Medicines |
Market Access |
Juli 31, 2024 |
| Associate Director, Access & Reimbursement RLT, Seattle, WA - Remote |
Field Non-Sales (USA) |
USA |
US |
Innovative Medicines |
Market Access |
Juli 19, 2024 |
| New Products & Strategic Pricing Partner |
Kyiv |
Ukraine |
International |
Innovative Medicines |
Market Access |
Apr 16, 2024 |
| Patient Access Lead |
Kyiv |
Ukraine |
International |
Innovative Medicines |
Market Access |
Apr 16, 2024 |